Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when AHR files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: AHR American Healthcare REIT, Inc. 8-K

American Healthcare REIT executes $2.1M share forward sale, settles by May 2028 for investments

Filed May 28, 2026 · Period ending May 26, 2026 · ~1 min read

4 key changes 1 high relevance 2 sections

Key Changes

  • high

    AHR will deliver 2.1M shares by May 2028 to receive cash at offering price minus underwriting discount, with option to settle in cash or net shares instead of physical delivery.

  • medium

    BofA Securities borrowed and sold 2.1M shares on May 28, 2026 to hedge the forward agreement, creating immediate market supply before AHR receives any proceeds.

  • medium

    Net proceeds will fund the Operating Partnership for general corporate purposes and potential healthcare real estate investments when settlement occurs.

  • medium

    Transaction stems from underwriter's full exercise of over-allotment option for additional 2.1M shares under forward sale structure with BofA affiliate.

Summary

American Healthcare REIT disclosed a forward sale agreement tied to the underwriter's over-allotment option exercise. Under this structure, BofA Securities has already borrowed and sold 2.1 million shares into the market as of May 28, 2026, but AHR won't receive cash proceeds until it physically settles the transaction—no later than May 2028. This creates a roughly two-year gap between share dilution and capital receipt.

For shareholders, this means immediate dilution pressure (2.1M shares now trading) without the offsetting benefit of new capital deployed into income-generating properties until settlement. The company retains flexibility to settle in cash or net shares rather than physical delivery, which could reduce actual dilution if the stock price moves favorably. Watch for how management deploys these proceeds once received—whether into accretive healthcare property acquisitions or lower-return general corporate uses—and monitor the stock price relative to the forward price to gauge settlement method likelihood.

Section-by-Section Diff

Event · Item 8.01 — Other Events

~500 words

AHR exercised underwriter option for 2.1M shares via forward sale agreement, settling by May 2028 for proceeds to fund investments.

4 Added
Added Underwriter option exercise via forward sale medium

Added in current filing · verify on EDGAR →

On May 26, 2026, in connection with the exercise in full of the Underwriter’s option to purchase additional shares, or the option exercise, we entered into an additional forward sale agreement, or the Additional Forward Sale Agreement, with an affiliate of the Underwriter, as forward purchaser, or in such capacity, the Forward Purchaser.

American Healthcare REIT entered into an additional forward sale agreement on May 26, 2026, following the full exercise of the underwriter's option to purchase 2,100,000 additional shares of common stock. This agreement is with an affiliate of BofA Securities, Inc. acting as forward purchaser.

Added Forward seller share borrowing and sale medium

Added in current filing · verify on EDGAR →

In connection with the option exercise, BoA Securities, Inc., as forward seller, or in such capacity, the Forward Seller, borrowed and sold an aggregate of 2,100,000 shares of Common Stock on May 28, 2026 to hedge the Forward Purchaser’s obligations under the Additional Forward Sale Agreement.

BofA Securities borrowed and sold 2,100,000 shares on May 28, 2026, to hedge the forward purchaser's obligations. This is a standard hedging mechanism in forward sale agreements where shares are sold into the market before the company physically settles the transaction.

Added Settlement terms and timeline high

Added in current filing · verify on EDGAR →

We intend (subject to our right to elect cash or net share settlement subject to certain conditions) to deliver, upon physical settlement of the Additional Forward Sale Agreement on one or more dates specified by us occurring no later than May 20, 2028 (or if such date is not a trading day, the next following trading day), an aggregate of 2,100,000 shares of Common Stock to the Forward Purchaser in exchange for cash proceeds per share equal to the applicable forward sale price, which will be the public offering price less the underwriting discount and subject to certain adjustments as provided in the Additional Forward Sale Agreement.

The company intends to physically settle the forward sale agreement by delivering 2,100,000 shares to the forward purchaser no later than May 20, 2028, in exchange for cash proceeds equal to the public offering price minus underwriting discount. The company retains the right to elect cash or net share settlement under certain conditions, providing flexibility in how the transaction is ultimately settled.

Added Use of proceeds medium

Added in current filing · verify on EDGAR →

We intend to contribute the net proceeds from the settlement of the Additional Forward Sale Agreement to American Healthcare REIT Holdings, LP, or our Operating Partnership, in exchange for units of limited partnership interest in the Operating Partnership, and the Operating Partnership intends to use such net proceeds for general corporate purposes, including potential future investments.

The net proceeds from settling the forward sale agreement will be contributed to the company's Operating Partnership in exchange for limited partnership units. The Operating Partnership plans to use these proceeds for general corporate purposes, including potential future investments in healthcare real estate properties.

Event · Item 9.01 — Financial Statements and Exhibits

~200 words

American Healthcare REIT entered a forward stock sale confirmation with BofA Securities on May 26, 2026.

1 Added
Added Forward stock sale agreement medium

Added in current filing · verify on EDGAR →

Forward Confirmation, dated May 26, 2026, between the Company and BofA Securities, Inc. (or its affiliate)

The company executed a forward confirmation agreement with BofA Securities on May 26, 2026. Forward confirmations are typically used in equity offerings where the company agrees to issue shares at a future date at a price based on the stock's performance during a specified period. This suggests the company is raising capital through a forward equity sale arrangement.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 28, 2026 · How we verify